Tools & Techniques

Integrating multiplexed immunohistochemistry with spatial analysis offers a practical way to uncover tumor-immune dynamics.

Explore manufacturability, purification strategies, and expected yields for over 70 bispecific antibody formats to support informed decision-making in therapeutic development.

With over 100 formats to choose from, designing bispecific antibodies demands both a clear understanding and the right tools to bring them to life.

Integrated software and AI are accelerating drug discovery through faster analysis and smarter decisions.

AI-enhanced, cloud-native solutions can help researchers address barriers to collaborative drug discovery projects.

New techniques in 3D cell culture are transforming how researchers study organoids and translate biological complexity into drug discovery insights.

Advances in microfluidics are enabling more powerful, high throughput applications in single cell and therapeutic discovery.

Collaboration to leverage Oxford Nanopore’s sequencing platform and Cepheid’s GeneXpert system to advance the field of sequencing for infectious diseases.

Scientists are turning to breath samples as a way to detect tuberculosis economically and conveniently.

Collaboration combines Scipher’s unique RNAseq data with InnoSIGN’s proprietary comprehensive pathway analysis (CPA) platform to enhance the understanding of complex immune-mediated diseases.

Integrating scientific and engineering expertise is critical for enabling faster, more cost-effective drug discovery. 

Key scientific achievements expand the pipeline of high value molecular glue degraders for unmet medical needs.

Validated drug discovery assay overcomes previous challenges in targeting NaV1.9 ion channels for chronic pain signalling

Next-generation natural refrigerant cooling system for centrifuges, offering a lower Global Warming Potential and reduced energy consumption.

EpiCypher has launched meCUT&RUN and Multiomic CUT&RUN, two cost-effective tools for high-resolution DNA methylation and multiomic epigenomic profiling.

Bruker has launched Beacon Discovery™, a benchtop system for live single-cell analysis designed for broader use in academic and translational research.

Built on the legacy of three trusted brands – BioTrading, Redipor by Cherwell, and NEL – Redipor by AnalytiChem brings together over 150 years of prepared media expertise, innovation and heritage into one unique global brand.